NCT00141765View on ClinicalTrials.gov

Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 1997

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2010

Conditions
Wilms TumorFibrosarcomaCarcinoma, Round CellNasopharyngeal CancerBrain Tumor, Recurrent
Interventions
PROCEDURE

Myeloablative Chemotherapy

High dose chemotherapy (carboplatin and thiotepa) transplant rescue

PROCEDURE

Stem Cell Rescue

autologous stem cell transplantation

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00141765 - Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | Biotech Hunter | Biotech Hunter